Skip to main content

Table 1 Patient characteristics

From: Long-term costs of colorectal cancer treatment in Spain

  Colon Rectum Total
N 512 187 699
Age (years)    
 Mean 70.4 70.5 70.5
 Median 73.0 72.0 73.0
Sex (%)    
 Male 53.9 59.4 55.4
 Female 46.1 40.6 44.6
Year of diagnosis (%)    
 2000 13.3 12.3 13.0
 2001 14.3 15.5 14.6
 2002 15.0 14.4 14.9
 2003 17.0 13.4 16.0
 2004 17.0 13.9 16.2
 2005 11.5 12.8 11.9
 2006 11.9 17.6 13.4
TNM Stage (%)    
In situ 6.6 3.2 5.7
 I 11.7 14.4 12.5
 II 25.8 25.1 25.6
 III 23.2 29.4 24.9
 IV 21.3 18.7 20.6
 Unknown 11.3 9.1 10.7
Surgery (%)    
 Patients 68.9 75.4 70.7
 Surgical procedure    
  Right hemicolectomy 27.7 1.1 18.6
  Left hemicolectomy 5.5 0.7 3.8
  Sigmoidectomy 18.9 1.1 12.8
  Other colon resections 9.2 2.2 6.8
  Anterior resection of rectum 3.9 27.7 12.1
  Abdominoperineal resection 0.0 14.2 4.9
  Other rectal resections 0.8 10.9 4.2
  Liver metastases resection 3.5 3.4 3.5
  Other metastases resection 1.8 2.2 1.9
  Other procedures 28.8 36.3 31.4
Chemotherapy (%)    
 Patients 30.1 47.1 34.6
 Intention    
  Neoadjuvant 1.4 27.7 11.0
  Adjuvant 29.0 26.2 28.0
  Advanced disease - Palliative 63.7 44.1 56.6
  Unknown 5.9 2.0 4.5
 Treatment scheme    
  Fluorouracil +/− Levamisole 20.0 43.9 28.5
  Capecitabine +/− Irinotecan/Oxaliplatin 23.8 16.6 21.3
  Irinotecan - Fluorouracil +/− Leucovorin 14.7 17.1 15.6
  Oxaliplatin - Fluorouracil +/− Leucovorin 12.1 7.5 10.4
  Cetuximab - Irinotecan 10.3 3.2 7.8
  Others 19.1 11.8 16.5
Radiotherapy (%)    
 Patients 7.2 48.7 18.3
 Intention    
  Radical 39.5 74.5 64.4
  Palliative 60.5 25.5 35.6